Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPN1 | P15169 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25395272 | 0.85 | CPN1 (0.40) | CPN1CPB2SIGMAR1HTR2AKCNH2 | |
| SCHEMBL23709494 | 0.85 | CPN1 (0.40) | CPN1CPB2SIGMAR1HTR2AKCNH2 | |
| SCHEMBL28035328 | 0.84 | CPN1 (0.42) | CPN1CPB2SIGMAR1HTR2AKCNH2 | |
| SCHEMBL4290504 | 0.82 | CPN1 (0.41) | CPN1CPB2SIGMAR1DPP7 | |
| SCHEMBL13285534 | 0.82 | CPN1 (0.38) | CPN1CPB2SIGMAR1HTR2AKCNH2 | |
| SCHEMBL4290481 | 0.82 | CPN1 (0.41) | CPN1CPB2SIGMAR1DPP7 | |
| SCHEMBL26489011 | 0.81 | CPN1 (0.37) | CPN1CPB2SIGMAR1HTR2AGNAI3 | |
| SCHEMBL820657 | 0.80 | CPN1 (0.44) | CPN1CPB2KCNH2 | |
| SCHEMBL9340322 | 0.80 | CPN1 (0.40) | CPN1CPB2SIGMAR1HTR2AKCNH2 | |
| SCHEMBL21725498 | 0.79 | CPN1 (0.38) | CPN1CPB2HTR2AGNAI3GNAO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2506966-B1 | CATALYST AND METHOD FOR PRODUCING AN AMINE | BASF SE (DE) | 2017-08-16 | — | — | EP | disclosed |
| EP-2506965-B1 | CATALYST AND METHOD FOR PRODUCING AN AMINE | BASF SE (DE) | 2016-11-09 | — | — | EP | disclosed |
| US-9409154-B2 | Process for producing Sn-comprising catalysts | BASF SE (DE) | 2016-08-09 | — | — | US | disclosed |
| EP-2225029-B1 | METHOD AND CATALYST FOR PRODUCING AN AMINE | BASF SE (DE) | 2016-08-03 | — | — | EP | disclosed |
| EP-2780109-B1 | PROCESS FOR PRODUCING SN-CONTAINING CATALYSTS | BASF SE (DE) | 2016-04-13 | — | — | EP | disclosed |
| US-20150224480-A1 | PROCESS FOR PRODUCING SN-COMPRISING CATALYSTS | BASF SE (DE) | 2015-08-13 | — | — | US | disclosed |
| EP-2883862-A1 | Method for manufacturing amines | BASF SE (DE) | 2015-06-17 | — | — | EP | disclosed |
| US-9040451-B2 | Process for producing Sn-comprising catalysts | BASF SE (DE) | 2015-05-26 | — | — | US | disclosed |
| US-8765634-B2 | Processes for preparing amines and zirconium dioxide- and nickel-containing catalysts for use therein | BASF SE (DE) | 2014-07-01 | — | — | US | disclosed |
| US-20130310560-A1 | PROCESSES FOR PREPARING AMINES AND CATALYSTS FOR USE THEREIN | BASF SE (DE) | 2013-11-21 | — | — | US | disclosed |
| US-20100274008-A1 | METHOD FOR THE PRODUCTION OF AN AMINE | BASF SE (DE) | 2010-10-28 | — | — | US | disclosed |
| US-20100274011-A1 | METHOD FOR THE PRODUCTION OF AN AMINE | BASF SE (DE) | 2010-10-28 | — | — | US | disclosed |
| US-7754922-B2 | Process for preparing amines and zirconium dioxide- and nickel-containing catalysts for use therein | BASF SE (DE) | 2010-07-13 | — | — | US | disclosed |
| US-7750189-B2 | Method for producing an amine | BASF SE (DE) | 2010-07-06 | — | — | US | disclosed |
| US-20100010264-A1 | METHOD FOR PRODUCING AN AMINE | BASF SE (DE) | 2010-01-14 | — | — | US | disclosed |
| US-20090312579-A1 | METHOD FOR PRODUCING AN AMINE | BASF SE (DE) | 2009-12-17 | — | — | US | disclosed |
| US-20090286977-A1 | METHOD FOR PRODUCING AN AMINE | BASF SE (DE) | 2009-11-19 | — | — | US | disclosed |
| US-20090275781-A1 | METHOD FOR PRODUCING AN AMINE | BASF SE (DE) | 2009-11-05 | — | — | US | disclosed |
| US-20090264652-A1 | METHOD FOR PRODUCING AN AMINE | BASF SE (DE) | 2009-10-22 | — | — | US | disclosed |
| US-4605742-A | Process for the production of piperidine | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1986-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130310560-A1 | PROCESSES FOR PREPARING AMINES AND CATALYSTS FOR USE THEREIN | AOC3, SCO2, SOD1 | CPN1 1513/4885CPB2 3123/4885SIGMAR1 1200/4885 |
| US-20090312579-A1 | METHOD FOR PRODUCING AN AMINE | AOC3, AOC2, ADH5 | CPN1 1648/4885CPB2 4150/4885SIGMAR1 842/4885 |
| US-20100274008-A1 | METHOD FOR THE PRODUCTION OF AN AMINE | AOC3, AOC2, SOD1 | CPN1 956/4885CPB2 3709/4885SIGMAR1 529/4885 |
| US-20090275781-A1 | METHOD FOR PRODUCING AN AMINE | AOC3, AOC2, AOC1 | CPN1 1193/4885CPB2 3576/4885SIGMAR1 577/4885 |
| US-20100010264-A1 | METHOD FOR PRODUCING AN AMINE | AOC2, AOC3, SOD1 | CPN1 1272/4885CPB2 2649/4885SIGMAR1 903/4885 |
| US-20090286977-A1 | METHOD FOR PRODUCING AN AMINE | SOD1, AOC3, AOC2 | CPN1 869/4885CPB2 2956/4885SIGMAR1 950/4885 |
| US-20100274011-A1 | METHOD FOR THE PRODUCTION OF AN AMINE | SCO2, AOC3, AOC2 | CPN1 1824/4885CPB2 2401/4885SIGMAR1 989/4885 |
| US-20090264652-A1 | METHOD FOR PRODUCING AN AMINE | AOC3, ADH5, ADH1A | CPN1 1427/4885CPB2 4099/4885SIGMAR1 713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.